BENIGN PROSTATIC HYPERTROPHY
Conditions
Interventions
Trade Name: TRANEXAMIC ACID
Product Name: AMCHAFIBRIN
Pharmaceutical Form: Solution for infusion
INN or Proposed INN: TRANEXAMIC ACID
Other descriptive name: TRANEXAMIC ACID
Concentration unit: mg/ml
Sponsors
CARLOS SANTOS VILLAR
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: MALE OVER 50 YEARS PERFORMING TRANSURETHRAL RESECTION OF PROSTATE OR RETROPUBIC ADENOMECTOMY BECAUSE OF BENIGN PROSTATIC HYPERTROPHY Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 50 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 48
Exclusion criteria
Exclusion criteria: PATIENT REFUSAL TO THEIR PARTICIPATION IN THE STUDY. EMEPERGENCY SURGERY. PAST OF ARTERIAL OR VENOUS THROMBOSIS. THROMBOFILIA. KIDNEY INJURY. PAST OF CONVULSION
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: COMPARING PERIOPERATIVE ANEMIA;Secondary Objective: NEED FOR TRANSFUSION COMPLICATIONS LENGTH OF HOSPITAL STAY;Primary end point(s): HEMOGLOBIN, HEMATOCRIT, PLATELETS, COAGULATIONS TIMES, FIBRINOGEN;Timepoint(s) of evaluation of this end point: FIRST DAY AND FIFTH DAY | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): NEED FOR TRANSFUSION COMPLICATIONS LENGTH OF HOSPITAL STAY;Timepoint(s) of evaluation of this end point: FIRST DAY AND FIFTH DAY | — |
Countries
Spain
Contacts
Public ContactSERVICIO DE ANESTESIA
HOSPITAL GALDAKAO-USANSOLO
Outcome results
None listed